R & D Committee Communication from the Committee
-
“Agreement on Standard Operating Procedures for Treating Recombinant Viruses Without the Ability to Proliferate Independently, Used in the Production of Transgenic Cells, as Non-Existent” (PDF: 171 KB)
After confirmation by the R & D Committee, a document was issued on March 20, Heisei 27, to serve as a reference for handling the relevant samples under the responsibility of each company.
Note that this document has been submitted to the Office of Bioethics and Safety Measures, Life Sciences Division, Bureau of Research Promotion, Ministry of Education, Culture, Sports, Science and Technology. -
“Regulatory Treatment Under the Cartagena Act Regarding Proteins Affinity-Purified from Recombinant Baculoviruses Infected in and Proliferated in Silkworm or Insect Cells” (PDF: 161 KB)
This document was approved at the Joint Meeting of the R & D Committee on March 29, Reiwa 3, and was issued as a reference document for handling the relevant samples under the responsibility of each company.
Furthermore, this document has been submitted to the Office of Bioethics and Safety Measures, Life Sciences Division, Bureau of Research Promotion, Ministry of Education, Culture, Sports, Science and Technology (MEXT), as well as to the Office of Biodiversity and Biological Weapons Countermeasures, Biochemical Industry Division, Commerce and Services Group, Bureau of Commerce and Information Policy, Ministry of Economy, Trade and Industry (METI). -
[Nikkan Yakugyo Series “Toward an Era of Co-Creation” (16)] TPP Overview Published to Aid in Bridging the Gap—Tsukahara, Chairperson of the Research and Development Committee
An interview with Research and Development Chairperson Tsukahara was published in the Nikkan Yakugyo.
Nikkan Yakugyo, published September 20, 2025 [Permission No. 20250930_03]
Jihou Co., Ltd. has granted permission to use this article.